These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7867168)

  • 1. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment.
    Pietersma A; Kofflard M; de Wit LE; Stijnen T; Koster JF; Serruys PW; Sluiter W
    Circulation; 1995 Mar; 91(5):1320-5. PubMed ID: 7867168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis.
    Cipollone F; Fazia M; Iezzi A; Pini B; Costantini F; De Cesare D; Paloscia L; Materazzo G; D'Annunzio E; Bucciarelli T; Vecchiet J; Chiarelli F; Cuccurullo F; Mezzetti A
    Heart; 2003 Jul; 89(7):773-9. PubMed ID: 12807855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
    Foley DP; Melkert R; Serruys PW
    Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for early reocclusion and luminal renarrowing in patients with acute coronary syndromes treated by direct PTCA with provisional stenting.
    Tölg R; Hartmann F; Adlar S; Kurz T; Kurowski V; Katus HA; Richardt G
    Z Kardiol; 2000 Jun; 89(6):485-94. PubMed ID: 10929432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
    Melkert R; Violaris AG; Serruys PW
    J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
    Cipollone F; Marini M; Fazia M; Pini B; Iezzi A; Reale M; Paloscia L; Materazzo G; D'Annunzio E; Conti P; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):327-34. PubMed ID: 11231910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect evidence for a role of a subpopulation of activated neutrophils in the remodelling process after percutaneous coronary intervention.
    Costa MA; de Wit LE; de Valk V; Serrano P; Wardeh AJ; Serruys PW; Sluiter W
    Eur Heart J; 2001 Apr; 22(7):580-6. PubMed ID: 11259145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.
    Inoue T; Sohma R; Miyazaki T; Iwasaki Y; Yaguchi I; Morooka S
    Am J Cardiol; 2000 Nov; 86(10):1057-62. PubMed ID: 11074199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris.
    Halon DA; Merdler A; Shefer A; Flugelman MY; Lewis BS
    Am J Cardiol; 1989 Aug; 64(5):289-93. PubMed ID: 2526992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
    Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
    Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Fujikawa H; Shimada K
    Atherosclerosis; 2001 May; 156(1):165-70. PubMed ID: 11369010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty.
    Tashiro H; Shimokawa H; Sadamatsu K; Aoki T; Yamamoto K
    Coron Artery Dis; 2001 Mar; 12(2):107-13. PubMed ID: 11281299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis.
    Bauters C; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Circulation; 1995 Nov; 92(9):2473-9. PubMed ID: 7586347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.